McDermott Will & Schulte, a global law firm

Brad Dennis represents a broad range of healthcare organizations, with a particular focus on complex transactions involving health systems, health plans, innovative joint ventures, and value-based care models. He works with health systems, health plans, investors, and other providers to design and execute deals that advance clinical, financial, and strategic objectives in the evolving healthcare ecosystem.

In the hospital sector, Brad advises nonprofit and for-profit health systems and academic medical centers on acquisitions, divestitures, affiliations, and joint ventures. He is known for balancing governance, regulatory, and business considerations in ways that keep deals moving and create durable partnerships.

Brad centers a significant portion of his practice  on healthcare joint ventures. He has extensive experience structuring and negotiating hospital service line partnerships, joint ventures, and other multiparty collaborations involving health systems, health plans, and for-profit platforms. He is recognized for navigating complex investment, governance, and regulatory issues to align diverse stakeholders and support growth.

In the managed care space, Brad advises on health plan acquisitions; joint ventures; and the development of provider-sponsored health plans, risk-bearing entities, and value-based care “enabler” models. He is at the forefront of transactions that bring providers and payers together, helping organizations evaluate risk, align incentives, and advance sustainable value-based strategies.

Clients rely on Brad for his practical decision-making, deep industry insight, and ability to deliver innovative solutions that bridge business and clinical priorities. He is a trusted advisor in the boardroom and at the deal table, helping organizations make confident decisions in transactions that reshape markets and define the next generation of healthcare models.

Kate McDonald represents clients across the healthcare industry on complex regulatory matters and high-stakes mergers and acquisitions, affiliations and other investments. She delivers strategic advice on federal and state laws applicable to health insurers and HMOs, including the downstream implications for their provider organizations and vendors, as well as the reimbursement landscape of federal healthcare programs.

Kate’s clients rely on her extensive experience navigating the Medicare Advantage, Medicare Part D and Medicaid managed care programs. She partners with health plans, provider organizations, technology start-ups, private equity funds and retailers to benchmark risks, solve regulatory challenges and structure transactions, particularly those that involve federal and state healthcare programs. As payors and providers continue to realign in today’s market, Kate offers nuanced insights into the unique obstacles and opportunities facing companies at the intersection of these two worlds. She helps innovative companies navigate state risk-bearing regulations, drafts and negotiates agreements with complex reimbursement structures and regulatory implications, and advises healthcare companies and private equity funds on investments in highly regulated segments of the healthcare market.

Kate’s healthcare regulatory experience also includes deep insights into DC certificate of need (CON) laws. She helps providers obtain CON approval for the introduction and expansion of healthcare services, changes in ownership, capital expenditures, and closure of healthcare services or facilities in Washington, DC.

Kate is a contributing author to Regulation of Medicare Part D Plans (Thomson Reuters, 2019 edition) and Thomson Reuters Health Law Handbook (2017 edition). She speaks regularly at healthcare industry events, including the Wall Street Journal Health Forum, American Health Lawyers Association Institute for Health Plan Counsel, Blue Cross Blue Shield National Summit, Health Care Compliance Association Managed Care Compliance Conference, and Medicaid Managed Care Congress. Kate was the first recipient of the McDermott Will & Emery Client Service Award (2019).

Matt Perreault advises healthcare organizations on complex transactions, sophisticated managed care arrangements, and related fraud and abuse matters. He represents accountable care organizations (ACOs); diverse provider, risk intermediary, care management and provider enablement organizations; health plans; and investors on a wide range of value-based care agreements, including shared savings, bundled payments, downside risk and capitation arrangements.

Matt serves as a strategic advisor to ACOs, independent physician associates (IPAs), managed care networks, integrated delivery networks and other healthcare providers, including hospitals and health systems, specialty providers, physician practices and innovative primary care organizations, on acquisitions, affiliations, reorganizations and other transactions. He also provides guidance on regulatory and fraud and abuse matters related to these transactions and contractual arrangements, including the physician self-referral law (Stark Law), the Anti-Kickback Statute, and general healthcare law and compliance matters.

Prior to joining McDermott Will & Schulte, Matt was deputy general counsel of a large national private health system, where he served as the lead lawyer for its managed care network, multi-specialty physician practice and hospital physician contracting throughout the system.